Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:42 AM UTC
| NCT Number | NCT06152575 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 492 participants |
| Active Locations | 100 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 24, 2026 (Aug 24, 2026) |
As of October 15, 2026: Clinical trial NCT06152575 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 100 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06152575 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 100 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06152575 was last updated Aug 24, 2026 (August 24, 2026). HelloStudys verifies this status automatically.